Zydus Wellness Ltd on May 19 reported 15% jump in net profit at Rs 172 crore for the quarter ended March 31, 2025. Advisory Alert: It has come to our attention that certain individuals are ...

AHMEDABAD, India & VALENCE, France, April 25, 2025--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical SA (Paris:AMPLI): Following the joint announcement of March 11, 2025, Zydus Lifesciences ...

Zydus Wellness Ltd reported a 30 per cent increase in net profit to ₹341 crore for the fiscal year ended March 31, 2025, according to statement. The company’s consolidated net sales grew by 16 ...

New Delhi: Zydus Wellness Ltd on Monday reported a 14.4 per cent rise in consolidated net profit at Rs 171.9 crore in the fourth quarter ended March 31, 2025, driven by strong performance of its ...

The company’s net profit surged to Rs 346.9 crore in the fiscal year 2025 (FY25) from Rs 266.9 crore in FY24 With Glucon-D and Sugar Free brand maintaining their market position, Zydus Wellness ...

Zydus Lifesciences on Saturday said it received six observations from the US Food and Drug Administration (USFDA) following a surveillance inspection of its active pharmaceutical ingredient (API ...

Zydus Lifesciences and Amplitude Surgical SA confirm that Amplitude has conducted the mandatory information and consultation process with the works council of Amplitude SAS. Consequently, Zydus has ...

Zydus Lifesciences Ltd on April 30 announced that it has got final US Food and Drug Administration (USFDA) approval for Niacin Extended-Release Tablets USP. The approval is for 500 mg, 750 mg, and ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. The Tribune, now published from ...